Under intense pressure from US over "insidious" tax loopholes, Pfizer and Allergan call off record $160 billion merger

Staff Writer

Columbus CEO

NEW YORK (AP) — Under intense pressure from US over "insidious" tax loopholes, Pfizer and Allergan call off record $160 billion merger.